Stay updated on Empagliflozin in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page shows the completed empagliflozin heart-failure study record, with details on its crossover design, participant criteria, measured outcomes, dates, and related publications.SummaryDifference46%

- Check11 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision updates to v3.7.2. The study record remains inaccessible with a 403 error.SummaryDifference1%

- Check39 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previously visible trial details and sections. This indicates an access issue preventing users from viewing the EMPA trial information.SummaryDifference18%

- Check60 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This appears to be a software version update for the page rather than a change to study content or results.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.